An overview of similarities and differences in metabolic actions and effects of central nervous system between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose Co-Transporter-2 inhibitors (SGLT-2is)
So, were going to break down exactly what it costs to use semaglutide for weight loss, and how GLP-1 agonists compare to popular alternatives
J Biochem Mol Biol
In the 72-week SURMOUNT-5 trial described in this article, average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide among adults with obesity without type 2 diabetes
Ron Grisanti, D.C., D.A.B.C.O., D.A.C.B.N., M.S., DIANM, CFMP is the founder of Functional Medicine University and author of The Medical Detective Reports. Read his full bio here
GLP-1s have been on the market for years now, with as many as 1 in 8 adult Americans using them at some point